論文（英文）

Ishiguro C, Takeuchi Y, Uyama Y, Tawaragi T. The MIHARI Project: Establishing a new framework for pharmacoepidemiological drug safety assessments by the Pharmaceuticals and Medical Devices Agency of Japan. Pharmacoepidemiol Drug Saf. 2016; 25(7): 854–859.
Takano A, Miyamoto Y, Kawakami N, Matsumoto T, Shinozaki T, Sugimoto T. Web-based cognitive behavioral relapse prevention program with tailored feedback for people with methamphetamine and other drug use problems: protocol for a multicenter randomized controlled trial in Japan. BMC Psychiatry. 2016;16:87.
Matsumoto M, Kato M, Oba K, Abiko S, Tsuda M, Miyamoto S, Mizushima T, Ono M, Omori S, Takahashi M, Ono S, Mabe K, Nakagawa M, Nakagawa S, Kudo T, Shimizu Y, Sakamoto N. Multicenter randomized controlled study to assess the effect of prophylactic clipping on post-polypectomy delayed bleeding. Dig Endosc. 2016 Mar 28. doi: 10.1111/den.12661.
Kishikawa J, Kazama S, Oba K, Hasegawa K, Anzai H, Harada Y, Abe H, Matsusaka K, Hongo K, Oba M, Yasuda K, Otani K, Nishikawa T, Tanaka T, Tanaka J, Kiyomatsu T, Hata K, Kawai K, Nozawa H, Yamaguchi H, Ishihara S, Sunami E, Ushiku T, Kitayama J, Fukayama M, Kokudo N, Watanabe T. CD133 Expression at the Metastatic Site Predicts Patients' Outcome in Colorectal Cancer with Synchronous Liver Metastasis. Ann Surg Oncol. 2016 Jan 29. [Epub ahead of print]
Takeuchi Y, Bonkobara M. Receptor tyrosine kinase KIT: Prognostic and therapeutic involvement in canine mast cell tumours. Vet J. 2016; 210: 5–6.
Lee SL, Daimon M, Nakao T, Singer DE, Shinozaki T, Kawata T, Kimura K, Hirokawa M, Kato TS, Mizuno Y, Watanabe M, Yatomi Y, Yamazaki T, Komuro I. Factors influencing left atrial volume in a population with preserved ejection fraction: left ventricular diastolic dysfunction or clinical factors? J Cardiol. 2016;68(4):275-81.
Hiromasa T, Kuramitsu S, Shinozaki T, Jinnouchi H, Morinaga T, Kobayashi Y, Domei T, Soga Y, Shirai S, Ando K. Impact of total stent length after cobalt chromium everolimus-eluting stent implantation on 3-year clinical outcomes. Catheter Cardiovasc Interv. 2017;89(2):207-216.
Nakamura M, Muramatsu T, Yokoi H, Okada H, Ochiai M, Suwa S, Hozawa H, Kawai K, Awata M, Mukawa H, Fujita H, Shiode N, Asano R, Tsukamoto Y, Yamada T, Yasumura Y, Ohira H, Miyamoto A, Takashima H, Ogawa T, Ito S, Matsuyama Y, Nanto S; J-DESsERT investigators. Three-year follow-up outcomes of SES and PES in a randomized controlled study stratified by the presence of diabetes mellitus: J-DEsSERT trial. International Journal of Cardiology 2016; 208: 4-12.
Shindoh J, Makuuchi M, Matsuyama Y, Mise Y, Arita J, Sakamoto Y, Hasegawa K, Kokudo N. Complete removal of the tumor-bearing portal territory decreases local tumor recurrence and improves disease-specific survival of patients with hepatocellular carcinoma. Journal of Hepatology 2016; 64(3): 594-600.
Sakamoto Y, Kokudo N, Matsuyama Y, Sakamoto M, Izumi N, Kadoya M, Kaneko S, Ku Y, Kudo M, Takayama T, Nakashima O; Liver Cancer Study Group of Japan. Proposal of a new staging system for intrahepatic cholangiocarcinoma: Analysis of surgical patients from a nationwide survey of the Liver Cancer Study Group of Japan. Cancer 2016; 122(1): 61-70.
Omichi K, Shindoh J, Yamamoto S, Matsuyama Y, Akamatsu N, Arita J, Kaneko J, Sakamoto Y, Hasegawa K, Kokudo N. Postoperative outcomes for patients with non-B non-C hepatocellular carcinoma: A subgroup analysis of patients with a history of hepatitis B infection. Annals of Surgical Oncology 2015; 22(Suppl 3): 1034-1040.
TakaoT, Matsuyama Y, Suka M, Yanagisawa H, Iwamoto Y. The combined effect of visit-to-visit variability in HbA1c and systolic blood pressure on the incidence of cardiovascular events in patients with type 2 diabetes. BMJ Open Diabetes Res Care 2015 Nov 13;3(1):e000129.
Tabuchi T, Fujiwara T, Shinozaki T. Tobacco price increase and smoking behaviour changes in various subgroups: a nationwide longitudinal 7-year follow-up study among a middle-aged Japanese population. Tob Control. 2017;26:69-77.
Shimada H, Fukagawa T, Haga Y, Oba K. Does remnant gastric cancer really differ from primary gastric cancer? A systematic review of the literature by the Task Force of Japanese Gastric Cancer Association. Gastric Cancer 2016; 19(2):339-49.
Jinnouchi H, Kuramitsu S, Shinozaki T, Hiromasa T, Kobayashi Y, Morinaga T, Yamaji K, Soga Y, Shirai S, Ando K. Two-year clinical outcomes of the NOBORI biolimus-eluting stents versus XIENCE/PROMUS everolimus-eluting stents in small vessel disease. Catheter Cardiovasc Interv. 2016;88(5):E132-E138.
Yamaguchi R, Makino Y, Chiba F, Torimitsu S, Yajima D, Shinozaki T, Iwase H. Fluid-fluid level and pericardial hyperdense ring appearance findings on unenhanced postmortem CT can differentiate between postmortem and antemortem pericardial hemorrhage. AJR Am J Roentgenol. 2015;205(6):W568-77.
Irie M, Takeuchi Y, Ohtake Y, Suzuki H, Nagata N, Miyoshi T, Kagawa Y, Yamagami T. Imatinib mesylate treatment in a dog with gastrointestinal stromal tumors with a c-kit mutation. J Vet Med Sci. 2015; 77(11): 1535–1539.
Oba K. Statistical challenges for central monitoring in clinical trials: a review. Int J Clin Oncol 2016;21(1):28-37.
Munemoto Y, Kanda M, Ishibashi K, Hata T, Kobayashi M, Hasegawa J, Fukunaga M, Takagane A, Otsuji T, Miyake Y, Nagase M, Sakamoto J, Matsuoka M, Oba K, Mishima H. Capecitabine and oxaliplatin combined with bevacizumab are feasible for treating selected Japanese patients at least 75 years of age with metastatic colorectal cancer. BMC Cancer 2015;15:786.
Matsuda C, Honda M, Tanaka C, Fukunaga M, Ishibashi K, Munemoto Y, Hata T, Bando H, Oshiro M, Kobayashi M, Tokunaga Y, Fujii A, Nagata N, Oba K, Mishima H. Multicenter randomized phase II clinical trial of oxaliplatin reintroduction as a third- or later-line therapy for metastatic colorectal cancer-biweekly versus standard triweekly XELOX (The ORION Study). Int J Clin Oncol. 2015 Oct 16. [Epub ahead of print]

TOP